Items per page
Sort by

Send to:

Choose Destination

Results: 10

Cited In for PubMed (Select 7673104)


Difference of the naltrexone's effects in social drinkers by spicy food preference.

Lee JS, Kim SG, Jeong HJ, Kim JH, Yang YH, Jung WY.

J Korean Med Sci. 2014 May;29(5):714-8. doi: 10.3346/jkms.2014.29.5.714. Epub 2014 Apr 25.


Pharmacological approaches to reducing craving in patients with alcohol use disorders.

Haass-Koffler CL, Leggio L, Kenna GA.

CNS Drugs. 2014 Apr;28(4):343-60. doi: 10.1007/s40263-014-0149-3. Review.


Placebo group improvement in trials of pharmacotherapies for alcohol use disorders: a multivariate meta-analysis examining change over time.

Del Re AC, Maisel N, Blodgett JC, Wilbourne P, Finney JW.

J Clin Psychopharmacol. 2013 Oct;33(5):649-57. doi: 10.1097/JCP.0b013e3182983e73. Review.


Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?

Maisel NC, Blodgett JC, Wilbourne PL, Humphreys K, Finney JW.

Addiction. 2013 Feb;108(2):275-93. doi: 10.1111/j.1360-0443.2012.04054.x. Epub 2012 Oct 17. Review.


Maintenance medication for opiate addiction: the foundation of recovery.

Bart G.

J Addict Dis. 2012;31(3):207-25. doi: 10.1080/10550887.2012.694598. Review.


Dihydrocodeine/Agonists for alcohol dependents.

Ulmer A, Müller M, Frietsch B.

Front Psychiatry. 2012 Mar 23;3:21. doi: 10.3389/fpsyt.2012.00021. eCollection 2012.


Age at onset typology in opioid dependent men: an exploratory study.

De B, Mattoo SK, Basu D.

Indian J Psychiatry. 2002 Apr;44(2):150-60.


Pharmacoprophylaxis of alcohol dependence: Review and update Part II: Efficacy.

Grover S, Basu D, Bhateja G.

Indian J Psychiatry. 2007 Jan;49(1):26-33. doi: 10.4103/0019-5545.31515.


Sweet liking phenotype, alcohol craving and response to naltrexone treatment in alcohol dependence.

Garbutt JC, Osborne M, Gallop R, Barkenbus J, Grace K, Cody M, Flannery B, Kampov-Polevoy AB.

Alcohol Alcohol. 2009 May-Jun;44(3):293-300. doi: 10.1093/alcalc/agn122. Epub 2009 Feb 3.


GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse.

Carnicella S, Kharazia V, Jeanblanc J, Janak PH, Ron D.

Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8114-9. doi: 10.1073/pnas.0711755105. Epub 2008 Jun 9.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk